At the call of the World Federation of Hemophilia, World Hemophilia Day will be observed on April 17. This is not merely an awareness day, but an opportunity to recognize a silent human struggle that has long remained unseen and unheard. This year, the day will be observed with the theme “Diagnosis: First step to care,” emphasizing the reality that despite significant advancements in medical science, more than 75 percent of people living with hemophilia worldwide still remain undiagnosed in time. This figure reflects not only the limitations of healthcare systems but also a deep inequality where millions are deprived of treatment simply because their condition is never identified.

Hemophilia is a rare genetic disorder that affects the blood’s ability to clot. Under normal circumstances, when the body is injured, proteins known as clotting factors help stop bleeding. However, in individuals with hemophilia, these factors are either deficient or entirely absent, causing even minor injuries to result in prolonged bleeding. In many cases, the bleeding is internal—occurring in joints and muscles—which can gradually lead to severe pain, swelling, and permanent disability. One of the greatest challenges of this disease is that it is present from birth, yet its symptoms are not always evident in early life. When a child begins to move and sustain minor injuries, signs such as frequent bruising, prolonged bleeding from small cuts, difficulty stopping bleeding after injections, and joint swelling or pain may appear. Recognizing these signs in time can change the course of life, which is why the 2026 theme places diagnosis at the center.
Hemophilia is primarily of two types: Hemophilia A and Hemophilia B. Hemophilia A results from a deficiency of Factor VIII, while Hemophilia B is caused by a deficiency of Factor IX. Though symptoms are similar, severity depends on how low the level of the clotting factor is in the body. This disorder is linked to the X chromosome, which is why it predominantly affects males, while females are usually carriers of the gene. In some cases, the disease may arise even without any family history due to new genetic mutations.
The history of World Hemophilia Day is as inspiring as its purpose. It was first observed in 1989, and April 17 was chosen to honor the birth anniversary of Frank Schnabel, who dedicated his life to the care and rights of people with hemophilia. Today, this day symbolizes global efforts not only to spread awareness but also to improve access to healthcare services. This year’s theme reminds us that diagnosis is not just a medical process but the gateway to treatment. Without identification of the disease, neither treatment can begin nor proper care be provided. This is why in many parts of the world, especially in developing countries, diagnosis is delayed due to lack of laboratories, trained professionals, and awareness. The problem is even more severe in cases of von Willebrand disease and other bleeding disorders, particularly among women and girls, whose symptoms often go unnoticed.
Diagnosis of hemophilia involves various tests, including clotting time tests, measurement of clotting factor levels, and genetic testing. Along with this, the patient’s medical history and family background are also critically important. This comprehensive evaluation not only confirms the disease but also determines its severity, guiding the course of treatment. While there is no permanent cure for hemophilia at present, modern medicine has made its effective management possible. Through factor replacement therapy, the deficient clotting factor is artificially supplied to control bleeding. Preventive treatment involves regular injections to reduce bleeding episodes. Additionally, newer options such as monoclonal antibody therapies have emerged, proving particularly effective for Hemophilia A patients. Physiotherapy and joint care are also essential components of treatment, enabling patients to lead a relatively normal life.
Although hemophilia is a genetic disorder and cannot be completely prevented, its impact can be minimized through awareness and genetic counseling. If there is a family history of the disease, timely testing and counseling can help future generations. Moreover, precautions in daily life—such as avoiding injuries, engaging in safe exercise, maintaining dental hygiene, and avoiding medications that increase bleeding—are extremely important. Overall, World Hemophilia Day urges us to reflect that health is not merely a matter of treatment but also a right to equal opportunity. Until every individual has access to timely diagnosis and treatment, the healthcare system will remain incomplete. Today, there is a need for collective efforts—governments, healthcare institutions, medical professionals, and society must work together to ensure that no one is deprived of treatment simply because their disease was never diagnosed. A timely diagnosis, even a small step, can save an entire life.

Email:------------------------------ mediacaregroup@gmail.com